Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-039926

VP and Chief Compliance Office gave up 2,560 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Herman James L VP and Chief Compliance Office 2021-03-17 Shares withheld for taxes −2,560 $3.22 $8,243 45,001 D
Derivatives
Herman James L VP and Chief Compliance Office 2021-03-17 Grant or award · Options (right to buy) +3,000 3,000 D
Loading xslF345X03/doc4.xml…